{"id":693,"date":"2018-01-30T13:59:13","date_gmt":"2018-01-30T18:59:13","guid":{"rendered":"https:\/\/piramalcriticalcare.com\/uk\/?page_id=693"},"modified":"2024-02-29T12:40:48","modified_gmt":"2024-02-29T17:40:48","slug":"summary-product-characteristics-patient-information-leaflet-3","status":"publish","type":"page","link":"https:\/\/piramalcriticalcare.com\/uk\/products\/pain-management\/rapifen-alfentanil-hydrochloride\/summary-product-characteristics-patient-information-leaflet-3\/","title":{"rendered":"Summary of Product Characteristics and Patient Information Leaflet"},"content":{"rendered":"<p>Rapifen is indicated for:<\/p>\n<ul>\n<li>In adults, as an opioid analgesic supplement for use before and during anaesthesia.<\/li>\n<li>Short procedures and outpatient surgery.<\/li>\n<li>Procedures of medium and long duration when given as a bolus followed by supplemental doses or by continuous infusion.<\/li>\n<\/ul>\n<p>At very high doses, Rapifen may be used in adults as an anaesthetic induction agent in ventilated patients.<\/p>\n<p>Rapifen is indicated for use in neonates, infants, children and adolescents as:<\/p>\n<ul>\n<li>an opioid analgesic in association with a hypnotic to induce anaesthesia<\/li>\n<li>an opioid analgesic in association with general anaesthesia and for both short and long surgical procedures<\/li>\n<\/ul>\n<p>For Rapifen Summary of Product Characteristics and Patient Information Leaflet, please <a href=\"https:\/\/products.mhra.gov.uk\/?search=Piramal&amp;page=1\" target=\"_blank\" rel=\"noopener\">click here<\/a>.<\/p>\n<p>Adverse events should be reported. Reporting forms and information can be found at <a href=\"http:\/\/www.mhra.gov.uk\/yellowcard\">www.mhra.gov.uk\/yellowcard<\/a><\/p>\n<p>Adverse events should also be reported to Piramal Critical Care at\u00a0<a href=\"https:\/\/piramalcriticalcare.com\/complaints\/\">https:\/\/piramalcriticalcare.com\/complaints\/<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Rapifen is indicated for: In adults, as an opioid analgesic supplement for use before and during anaesthesia. Short procedures and outpatient surgery. Procedures of medium and long duration when given as a bolus followed by supplemental doses or by continuous infusion. At very high doses, Rapifen may be used in adults as an anaesthetic induction [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":655,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"footnotes":""},"class_list":["post-693","page","type-page","status-publish","hentry"],"acf":[],"_links":{"self":[{"href":"https:\/\/piramalcriticalcare.com\/uk\/wp-json\/wp\/v2\/pages\/693","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/piramalcriticalcare.com\/uk\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/piramalcriticalcare.com\/uk\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/piramalcriticalcare.com\/uk\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/piramalcriticalcare.com\/uk\/wp-json\/wp\/v2\/comments?post=693"}],"version-history":[{"count":0,"href":"https:\/\/piramalcriticalcare.com\/uk\/wp-json\/wp\/v2\/pages\/693\/revisions"}],"up":[{"embeddable":true,"href":"https:\/\/piramalcriticalcare.com\/uk\/wp-json\/wp\/v2\/pages\/655"}],"wp:attachment":[{"href":"https:\/\/piramalcriticalcare.com\/uk\/wp-json\/wp\/v2\/media?parent=693"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}